BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 25424952)

  • 21. Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children.
    Guptan RC; Thakur V; Safary A; Sarin SK
    Vaccine; 2002 May; 20(16):2102-6. PubMed ID: 11972979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents.
    Beran J; Kervyn D; Wertzova V; Hobzova L; Tichy P; Kuriyakose S; Leyssen M; Jacquet JM
    Vaccine; 2010 Aug; 28(37):5993-7. PubMed ID: 20637766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial.
    Neuzil KM; Canh DG; Thiem VD; Janmohamed A; Huong VM; Tang Y; Diep NT; Tsu V; LaMontagne DS
    JAMA; 2011 Apr; 305(14):1424-31. PubMed ID: 21486975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
    Beran J; Van Der Meeren O; Leyssen M; D'silva P
    Vaccine; 2016 May; 34(24):2686-91. PubMed ID: 27105563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines.
    Ramonet M; da Silveira TR; Lisker-Melman M; Rüttimann R; Pernambuco E; Cervantes Y; Cañero-Velasco MC; Falleiros-Carvalho LE; Azevedo T; Targa-Ferreira C; Clemens SA
    Arch Med Res; 2002; 33(1):67-73. PubMed ID: 11825634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
    Shapiro AJ; Esther CR; Leigh MW; Dellon EP
    Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
    Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
    Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.
    Van Herck K; Van Damme P; Collard F; Thoelen S
    Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
    Van der Wielen M; Van Damme P; Chlibek R; Smetana J; von Sonnenburg F
    Vaccine; 2006 Jun; 24(26):5509-15. PubMed ID: 16725234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years.
    Levie K; Beran J; Collard F; Nguyen C
    Vaccine; 2002 Jun; 20(19-20):2579-84. PubMed ID: 12057615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
    Van Der Wielen M; Van Damme P; Collard F
    Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of the immunogenicity and safety of the Hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18 AS04-adjuvanted cervical cancer vaccine.
    Leroux-Roels G; Haelterman E; Maes C; Levy J; De Boever F; Licini L; David MP; Dobbelaere K; Descamps D
    Clin Vaccine Immunol; 2011 Sep; 18(9):1510-8. PubMed ID: 21734063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix.
    Greub G; Genton B; Safary A; Thoelen S; Frei PC
    Vaccine; 2000 Dec; 19(9-10):1113-7. PubMed ID: 11137246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa.
    Mugo N; Ansah NA; Marino D; Saah A; Garner EI
    Hum Vaccin Immunother; 2015; 11(6):1323-30. PubMed ID: 25912475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.
    Belderok SM; Sonder GJ; van Rossum M; van Dijk-Hummelman A; Hartwig N; Scherpbier H; Geelen S; Speksnijder AG; Baaten G; van den Hoek A
    Vaccine; 2013 Aug; 31(38):4156-63. PubMed ID: 23845818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers.
    De Schryver A; Verstrepen K; Vandersmissen L; Vandermeeren N; Vernaillen I; Vranckx R; Van Damme P; van Sprundel M
    J Viral Hepat; 2011 Apr; 18(4):e5-10. PubMed ID: 20735800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new accelerated vaccination schedule for rapid protection against hepatitis A and B.
    Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Vollmar J; Sänger R
    Vaccine; 2002 Jan; 20(7-8):1157-62. PubMed ID: 11803077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years.
    Marshall H; Nolan T; Díez Domingo J; Rombo L; Sokal EM; Marès J; Casanovas JM; Kuriyakose S; Leyssen M; Jacquet JM
    Vaccine; 2010 Jun; 28(27):4411-5. PubMed ID: 20434544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined two-dose hepatitis A and B vaccine (AmBirix).
    Jarvis B; Figgitt DP
    Drugs; 2003; 63(2):207-13; discussion 214-5. PubMed ID: 12515566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.